Cat IBD Long-Term Welfare Management

Managing inflammatory bowel disease in cats over the long term, addressing dietary management, medication, and quality of life monitoring.

Key Facts

Feline IBD is a spectrum of inflammatory conditions affecting up to 1% of domestic cats with increasing prevalence in older animals
Distinguishing IBD from alimentary small cell lymphoma requires intestinal biopsy; both may respond initially to similar treatment
Novel protein or hydrolysed protein diets achieve remission in approximately 30% of cats without medication
Long-term prednisolone use causes hypertension, diabetes risk, and muscle wasting, requiring monitoring
Cobalamin (B12) deficiency is common in IBD cats and supplementation improves response to treatment

Welfare Considerations

Chronic IBD profoundly affects quality of life through persistent gastrointestinal discomfort, nutritional deficiency, and treatment side effects. Long-term welfare management requires balancing disease control with minimizing medication burden. Regular monitoring including body condition scoring, appetite assessment, and cobalamin measurement enables proactive management and early detection of complications.

What You Can Do

Implement regular quality of life assessments using validated feline QoL tools
Monitor body weight and condition scoring monthly in IBD cats
Discuss cobalamin testing and supplementation with your vet at every reassessment
Keep a food and symptom diary to identify dietary triggers and treatment response
Explore lowest effective medication doses with your vet to minimise long-term side effects